Medical Device Developments Weekly
Medical Device Developments
Latest news and insight on innovations in the Medical Device sector.
Welcome to this week's Medical Device Developments newsletter.
See the latest insight and analysis from the global medical device market from the last week below:
Philips enhances its CT 5300 system for launch in North America
In February this year, Philips launched the CT 5300 system, featuring advanced AI capabilities for diagnosis, interventional procedures, and screening, at ECR2024.
The current upgrade builds on Philips’ CT Smart Workflow with a complete suite of AI-powered ‘Precise’ software solutions that support every step of the CT workflow.
Verathon launches single-use Spectrum QC eco video laryngoscope
Made using bio-based plastics, Spectrum QC eco combines an eco-friendly design with the performance capabilities of GlideScope.
The video laryngoscope features an 80% bio-based plastic shell, using the mass balance approach. It is certified by International Sustainability and Carbon Certification (ISCC PLUS).
Gravitas Medical receives FDA 510(k) clearance for Entarik technology
This approval allows the company to market its Entarik technology to the US neonatal market. The first FDA clearance was received in March 2023.
In December last year, the system earned a second FDA’s Breakthrough Device Designation. The Entarik System is designed for neonatal enteral feeding. It aids in placing the Entarik Enteral Feeding Tube into the stomach of neonatal patients requiring enteral feeding.
The 5G Future - Technological advancements are radically changing how surgeons can conduct surgeries remotely in new and exciting ways
A New Dimension in 3D Printing - 3D Printing is everywhere in medical manufacturing.
Manufacturing Class 3 Devices - Class 3 contract manufacturing is soaring.
ZwickRoell and Cormica® Medical Device & Pharmaceutical Testing MET Announce Strategic Partnership to Enhance Development Support for Early-Stage Innovations
As part of this partnership, ZwickRoell will connect its customers, particularly those in the initial phases of product development, to Cormica MET’s expertise and FDA-compliant testing capabilities.
This collaboration is designed to streamline the testing process, helping clients accelerate their journey from concept to market while ensuring compliance with regulatory standards.
DeepHealth partners with Siemens Healthineers, CARPL.ai platform
The UK-based company teamed up with Siemens Healthineers to create AI-powered SmartTechnology to enhance patient experience and operational efficiency in ultrasound.
The partnership combines Siemens Healthineers’ Acuson Sequoia ultrasound system, RadNet’s expertise in high-volume care, and DeepHealth’s SmartSonography solution.
Telix Pharmaceuticals Limited doses first patient in Phase 3 kidney cancer imaging agent trial in China
The late-stage trial uses TLX250-CDx as a positron emission tomography (PET) imaging agent for clear cell renal cell carcinoma (ccRCC).
The first patient was dosed and imaged at Beijing Cancer Hospital in China.TLX250-CDx (Zircaix) is an investigational PET agent being developed to noninvasively characterise indeterminate renal masses (IRMs) as ccRCC or non-ccRCC.
Upcoming webinars
Recommended webinars
- Meridian Bioscience: The Evolution of STI At-Home Testing Solutions
- Dupont Liveo: Designing smart wearables for improved performance & comfort
- WuxiApptec: Designing Extractable/Leachable Studies for Drugs and Biologics
- Loftware Siemens: The challenge of labeling & UDI for medical device
- Particle Measuring Systems: Environmental Monitoring Compliance Learning from FDA Warning Letters
- Rockwell Automation: A Unified Data Platform Delivers Integrated Pat and CPV
- IDAM: Identity and Access Management: A Modern Approach to Securing Your Business
Thanks for reading; we hope you enjoyed it.
Until next week.
To have a story featured on next week's newsletter - contact Medical Device Developments or Jamie Mann directly.
#MedicalDeviceDevelopments